PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy directly into fluid cavities shows promise for pancreatic cancer
Disease control Not yet recruitingThis study tests whether putting an immunotherapy drug (adebrelimab) directly into the chest or belly fluid can help control cancer-related fluid buildup in people with advanced pancreatic cancer. About 20 adults will receive the drug plus standard care. The goal is to see if thi…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sizhen Wang • Aim: Disease control
Last updated May 16, 2026 23:52 UTC
-
Personalized T-Cell therapy takes on pancreatic cancer
Disease control Not yet recruitingThis early-phase trial tests a new treatment called MT-601 for people with advanced pancreatic cancer that cannot be removed by surgery or has spread. MT-601 uses a patient's own immune cells, specially trained to attack multiple cancer targets, given alongside chemotherapy. The …
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: Marker Therapeutics, Inc. • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New vaccine-chemo combo takes on deadly pancreatic cancer
Disease control Not yet recruitingThis early-phase study tests a new tumor vaccine (SapDM275) given with standard chemotherapy (AG regimen) in 13 people with metastatic pancreatic cancer who haven't had prior treatment. The goal is to see if the combination is safe and shows signs of shrinking tumors. Participant…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: EARLY_PHASE1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for tough pancreatic cancer: combo therapy targets tumors after first-line fails
Disease control Not yet recruitingThis study tests a new drug (IBI363) combined with chemotherapy for people with advanced pancreatic cancer that has worsened after initial treatment. About 48 participants will receive the combination until the disease progresses or side effects become too severe. The goal is to …
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Can Lab-Grown organoids predict pancreatic cancer treatment success?
Knowledge-focused Not yet recruitingThis study looks at whether analyzing the genes of a patient's tumor and testing drugs on lab-grown mini-tumors (organoids) can predict how well standard chemotherapy will work. About 185 adults with metastatic pancreatic cancer will provide a biopsy sample for these tests. The r…
Matched conditions: PANCREATIC CANCER METASTATIC
Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME • Aim: Knowledge-focused
Last updated May 16, 2026 23:48 UTC